Minutia

📍 Oakland, United States🗓 Founded 2021👥 24 employees💰 Last funded Mar 2024
Biotechnology🌐 minutia.co
Website LinkedIn
We are working towards a transplant of insulin producing cells combined with nanosensors for diabetes that is so safe and effective we would put it in our own bodies and the bodies of people we love. We believe our ability to create more robust and controlled insulin producing cell transplants that can be monitored in vivo over time will revolutionize the current clinical landscape for diabetes and cell replacement therapy.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Minutia?
Minutia has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Minutia last raise funding?
The most recent investment in Minutia recorded on gritt.io was in March 2024.
When was Minutia founded?
Minutia was founded in 2021.
What industry is Minutia in?
Minutia operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Minutia based?
Minutia is headquartered in Oakland, United States.